Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,800
Sort by:
Minimal Residual Disease (MRD) Testing Market Size by Technology (Flow Cytometry, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and Others), Application (Hematological Malignancy, Solid Tumors), End User (Hospitals and Speciality Clinics, Diagnostic Laboratories, Academic and Research Institutes, and Others), and Region 2026-2034
US$ 2,999.00
The global minimal residual disease (MRD) testing market size reached USD 2.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.8 Billion by 2034, exhibiting a growth rat...
April 2026
149 pages
Cancer Diagnostics Market Report by Product (Consumables, Instruments), Technology (IVD Testing, Imaging, Biopsy Technique), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Region 2026-2034
US$ 2,999.00
The global cancer diagnostics market size reached USD 218.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 333.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4.68...
April 2026
147 pages
Circulating Tumor Cells (CTC) Market Report by Technology (CTC Detection and Enrichment Method, CTC Direct Detection Methods, CTC Analysis), Application (Clinical/Liquid Biopsy, Research), Product (Kits and Reagents, Blood Collection Tubes, Devices and Systems), Specimen (Blood, Bone Marrow, Other Body Fluids), End User (Hospital and Clinics, Research and Academic Institutes, Diagnostic Centres), and Region 2026-2034
US$ 2,999.00
The global circulating tumor cells (CTC) market size reached USD 14.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 28.0 Billion by 2034, exhibiting a growth rate (CAGR...
April 2026
136 pages
Tumor Ablation Market Report by Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, and Others), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation), Mode of Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Others), End-User (Hospitals, Cancer Specialty Clinics, and Others), and Region 2026-2034
US$ 2,999.00
The global tumor ablation market size reached USD 1,400 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 3,400 Million by 2034 , exhibiting a growth rate (CAGR) of 9.58 %...
April 2026
136 pages
Breast Lesion Localization Methods Market Report by Type (Wire Localization, Radioisotope Localization, Magnetic Tracers Localization, and Others), Usage (Tumor Identification, Sentinel Lymph Node Identification), End User (Hospitals, Diagnostic Centres, Oncology Clinics, Ambulatory Surgical Centers), and Region 2026-2034
US$ 2,999.00
The global breast lesion localization methods market size reached USD 1,436.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 3,010.8 Million by 2034, exhibiting a growth...
April 2026
136 pages
Oncology Information Systems Market Report by Product and Services (Software, Services), Application (Radiation Oncology, Medical Oncology, Surgical Oncology), End User (Hospitals and Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, Research Facilities), and Region 2026-2034
US$ 2,999.00
The global oncology information systems market size reached USD 4.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.4 Billion by 2034, exhibiting a growth rate (CAGR) o...
April 2026
148 pages
Oncology Molecular Diagnostics Market Report by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, and Others), Product (Instruments, Reagents, and Others), Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization, Chips and Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), Mass Spectrometry, DNA and NGS Sequencing, Transcription Mediated Amplification (TMA), and Others), End-User (Hospitals and Clinics, Reference Laboratories, and Others), and Region 2026-2034
US$ 2,999.00
The global oncology molecular diagnostics market size reached USD 5.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.1 Billion by 2034, exhibiting a growth rate (CAGR...
April 2026
138 pages
Oncolytic Virus Therapies Market Report by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2026-2034
US$ 2,999.00
The global oncolytic virus therapies market size reached USD 222.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 815.4 Million by 2034, exhibiting a growth rate (CAGR)...
April 2026
138 pages
In-vitro Colorectal Cancer Screening Tests Market Size, Share, Trends and Forecast by Product, Imaging Type, End User, and Region, 2026-2034
US$ 2,999.00
The global in-vitro colorectal cancer screening tests market size was valued at USD 1,101.3 Million in 2025. The market is projected to reach USD 1,709.7 Million by 2034, exhibiting a CAGR of 4.76% fr...
April 2026
142 pages
Liposomal Doxorubicin Market Report by Product (Doxil/Caelyx, Lipodox, Myocet, and Others), Application (Leukemia, Bone Sarcoma, Breast Cancer, Endometrial Cancer, Kidney Cancer, Multiple Myeloma, Kaposi Sarcoma, and Others), and Region 2026-2034
US$ 2,999.00
The global liposomal doxorubicin market size reached USD 1.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.53%...
April 2026
145 pages
Ovarian Cancer Market Report by Type (Epithelial Ovarian Cancer, Germ Cell Ovarian Cancer, Stromal Cell Ovarian Cancer), Treatment Type (Immunotherapy, Chemotherapy, Targeted Therapy, Surgery, and Others), End User (Hospitals, Homecare, Speciality Centre, and Others), and Region 2026-2034
US$ 2,999.00
The global ovarian cancer market size reached USD 2.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.8 Billion by 2034, exhibiting a growth rate (CAGR) of 9.21% during...
April 2026
139 pages
Cancer/Tumor Profiling Market Size, Share, Trends, and Forecast by Cancer Type, Technology, Technique, Application, and Region, 2026-2034
US$ 2,999.00
The global cancer/tumor profiling market size was valued at USD 13.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 27.3 Billion by 2034, exhibiting a CAGR of 7.89% du...
April 2026
149 pages
Tissue Diagnostics Market - 2026-2033
US$ 3,400.00
Tissue Diagnostics Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035. The Tissue Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...
March 2026
44 pages
Colorectal Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Diagnostic Kits & Assays, Instruments & Systems, Reagents & Consumables), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global colorectal cancer diagnostics market size was estimated at USD 9.53 billion in 2025 and is projected to reach USD 14.39 billion by 2033, growing at a CAGR of 5.34% from 2026 to 2033. The in...
March 2026
120 pages
Mantle Cell Lymphoma Market - 2024-2031
US$ 3,400.00
Mantle Cell Lymphoma Market reached US$ 2.9 billion in 2031 and, growing with a CAGR of 6.10% during the forecast period 2031-2035. The Mantle Cell Lymphoma Market emerges as a key focus in DataM Inte...
March 2026
46 pages
Global Bladder Cancer Kit Market Growth 2026-2032
US$ 3,660.00
The global Bladder Cancer Kit market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Bladder Cancer Kit is a medical...
March 2026
90 pages
Global Tumor Marker ELISA Kit Market Growth 2026-2032
US$ 3,660.00
The global Tumor Marker ELISA Kit market size is predicted to grow from US$ 2988 million in 2025 to US$ 4968 million in 2032; it is expected to grow at a CAGR of 7.7% from 2026 to 2032. Tumor marker E...
March 2026
109 pages
Noninvasive Cancer Diagnostics: Technologies and Global Markets
US$ 4,650.00
The global market for noninvasive cancer diagnostics was valued at $107.4 billion in 2016. This market is estimated to grow ... Diagnostic imaging technologies, the leading segment of this market, will grow from $43.6 billion in 2017 to $58.5 billion by 2022 with a CAGR of 6.1%. The market for advanced noninvasive ...
March 2026
188 pages
Cervical Cancer Diagnostics Market Report by Test Type (Pap Testing, HPV Testing, Cervical Biopsies, Colposcopy, and Others), Age Group (20 to 35 Years, Above 35 Years), and Region 2026-2034
US$ 2,999.00
The global cervical cancer diagnostics market size reached USD 8.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.8 Billion by 2034, exhibiting a growth rate (CAGR) o...
March 2026
143 pages
Brachytherapy Devices Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Seeds, Brachytherapy Afterloaders and Applicators, and Electronic Brachytherapy), Type (High-Dose Rate Brachytherapy Implant and Low-Dose Rate Brachytherapy Implant), Application (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, and Others), End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America)
US$ 4,450.00
The Brachytherapy Devices Market size was valued at US$1.04 billion in 2025 and is expected to reach US$1.93 billion by 2034. The brachytherapy devices market is estimated to register a CAGR of 7.2% d...
February 2026
290 pages
Brachytherapy Market Size, Share & Trends Analysis By Dosage Type (HDR, LDR), By Application (Prostate, Gynecological, Breast), By Product Seeds, Applicators & Afterloaders, Electronic Brachytherapy, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global brachytherapy market size is expected to reach USD 452.3 million by 2025, according to a ... growth of the brachytherapy market. Further key findings from the study suggest: In 2017, HDR brachytherapy held the largest market share in terms of ... . are some of the key players in the brachytherapy market.
January 2026
150 pages
Head and Neck Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics), By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others), By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing), By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy), By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Head and Neck Cancer Diagnostic Market is projected to expand significantly, growing from a valuation of USD 6.32 Billion in 2025 to USD 11.83 Billion by 2031, reflecting a compound annual...
January 2026
180 pages
Circulating Tumor Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Kits & Reagents, Blood Collection Tubes, Devices or Systems), By Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Circulating Tumor Cells Market to expand from USD 7.06 Billion in 2025 to USD 10.94 Billion by 2031 with a CAGR of 7.57%. The Global Circulating Tumor Cells Market is centered on cancer cel...
January 2026
185 pages
PD-L1 Biomarker Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cancer Type (NSCLC, Kidney Cancer, Melanoma, Head and Neck, Bladder Cancer, Others), By Assay Kit Type (PD-L1 22C3 IHC, PD-L1 28-8 IHC, PD-L1 SP263, PD-L1 SP142), By End Use (Research and Development, Diagnostics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global PD-L1 Biomarker Testing Market is projected to expand from USD 771.02 Million in 2025 to USD 1218.08 Million by 2031, reflecting a compound annual growth rate of 7.92%. This diagnostic sect...
January 2026
185 pages
Brain Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, Others), By Tumor Type (Metastatic, Meningioma, Glioblastoma, Pituitary Endoma, Others), By End User (Hospitals, Diagnostics Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Brain Cancer Diagnostics Market is projected to expand from USD 3.67 Billion in 2025 to USD 4.68 Billion by 2031, reflecting a compound annual growth rate of 4.13%. This sector encompasses...
January 2026
180 pages
Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Papillary Carcinoma, Follicular Carcinoma, Others), By Technique (Blood Test, Imaging, Biopsy, Others), By End-use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Thyroid Cancer Diagnostics Market is projected to expand from a valuation of USD 2.73 Billion in 2025 to USD 3.52 Billion by 2031, registering a compound annual growth rate of 4.33%. This s...
January 2026
181 pages
Breast Cancer Liquid Biopsy Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offerings (Assay & Reagents Kits, Instruments), By Circulating Biomarker (Circulating Tumor DNA, Circulating Tumor Cell, Extracellular Vesicles), By Application (Cancer Applications, Non-Cancer Applications), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Breast Cancer Liquid Biopsy Testing Devices Market is projected to expand significantly, rising from USD 895.36 Million in 2025 to USD 2345.46 Million by 2031, reflecting a CAGR of 17.41%....
January 2026
183 pages
Oncology Companion Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Product (Instrument, Consumables, Software), Service), By Technology (Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), Others), By Disease Type (Breast cancer, Non-small cell lung cancer, Colorectal cancer, Leukemia, Melanoma, Prostate cancer, Others), By End Use (Hospitals, Pathology/Diagnostic laboratory, Academic medical center), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oncology Companion Diagnostic Market is projected to expand from USD 3.21 Billion in 2025 to USD 5.07 Billion by 2031, registering a compound annual growth rate of 7.92%. These diagnostics...
January 2026
181 pages
Melanoma Diagnostics and Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Diagnostics Dermoscopy Devices, Biopsy Devices), By Therapeutics (Chemotherapy, Biological Therapy, Targeted Therapy, Immune Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Melanoma Diagnostics and Therapeutics Market is projected to expand from a valuation of USD 7.66 Billion in 2025 to USD 13.81 Billion by 2031, reflecting a CAGR of 10.32%. This market encom...
January 2026
180 pages
Genomic Cancer Panel & Profiling Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Tissue Testing (Solid Tissue Testing, Liquid Tissue Testing), By Cancer Panel Type (Single-Gene Panel, Multi-Gene Panel), By Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, Prostate Cancer, Others), By Application (Clinical, Research), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Others), By End-User (Hospitals, Clinical and Diagnostic Laboratories, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Genomic Cancer Panel & Profiling Market is projected to expand from a valuation of USD 11.09 Billion in 2025 to USD 19.16 Billion by 2031, registering a CAGR of 9.54%. These diagnostic tech...
January 2026
180 pages
Genomic Cancer Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Others), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC), Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Genomic Cancer Testing Market is projected to expand from USD 14.48 Billion in 2025 to USD 26.37 Billion by 2031, reflecting a CAGR of 10.51%. This market consists of diagnostic solutions d...
January 2026
185 pages
Immuno Oncology Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Colorectal Cancer, Lung Cancer, Melanoma Cancer, Bladder Cancer, Others), By Technology (Immunoassays, Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Flow Cytometry), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Immuno Oncology Assays Market is projected to expand from USD 5.47 Billion in 2025 to USD 8.21 Billion by 2031, registering a compound annual growth rate (CAGR) of 7.01%. These assays serve...
January 2026
180 pages
Sarcoma Biopsy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Product Type (Reusable Devices, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Sarcoma Biopsy Market is projected to expand from USD 300.56 Million in 2025 to USD 380.52 Million by 2031, reflecting a CAGR of 4.01%. Sarcoma biopsy serves as a critical diagnostic proces...
January 2026
180 pages
Refractory Follicular Lymphoma Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Kits & Consumables), By Method (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Polymerase Chain Reaction (PCR), Others), By End User (Hospitals, Diagnostic Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Refractory Follicular Lymphoma Diagnostics Market is projected to expand from USD 0.49 Billion in 2025 to USD 0.69 Billion by 2031, registering a CAGR of 5.87%. This sector comprises specia...
January 2026
180 pages
Next Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Next Generation Cancer Diagnostics Market is projected to expand from USD 16.02 Billion in 2025 to USD 25.89 Billion by 2031, registering a CAGR of 8.33%. These advanced diagnostic systems...
January 2026
181 pages
Cancer Biopsy Market ? Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Kits and Consumables, Services), By Type of Biopsy (Tissue Biopsies (Needle and Surgical Biopsies), Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cancer Biopsy Market is projected to expand from USD 36.73 Billion in 2025 to USD 68.59 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 10.97%. A cancer biopsy involves...
January 2026
181 pages
Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope (Iodine-131, Iodine-123, Gallium-68), By Approach (Targeted Therapeutic, Targeted Diagnostic), By Application (Oncology, Non-Oncology), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global radiotheranostics market size was estimated at USD 11.79 billion in 2025 and is projected to reach USD 25.56 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market represe...
January 2026
150 pages
